|
|
Apple engineers are working on third-party app store support in iOS (2 minute read)
Apple is reportedly working on changes to iOS that would allow users to access apps outside of the App Store. The changes will be implemented by 2024 in response to regulations from the EU. Apple is exploring ways to limit users' exposure to potentially malicious apps. Other changes are also planned in response to EU laws, such as opening more API features to third-party developers that were previously only available to Apple.
|
Instagram is adding a BeReal clone, a tweet-ish feature, and groups (2 minute read)
Instagram has announced new features for 2023, including Candid Stories, Notes, Group Profiles, and Collaborative Collections. Candid Stories is a BeReal clone that allows users to share images from their front and back cameras after receiving a daily notification reminder. Notes allows users to share up to 60 characters of text and emoji with a limited group of followers. Group Profiles allow users to make posts that remain within a group. Collaborative Collections is a feature that lets users save posts to groups or DM conversations.
|
Science & Futuristic Technology
|
World-First Trial Transfusing Lab-Grown Red Blood Cells Begins (4 minute read)
The world's first trial testing lab-grown red blood cells is underway in the UK. The study aims to find out whether red blood cells made in the laboratory can last longer than blood cells made in the body. If the lab-grown cells can last longer, it will mean that patients who require regular blood transfusions might not require them as frequently. The patients have so far reported no untoward side effects.
|
Cancer mRNA vaccine completes pivotal trial (2 minute read)
A trial of a cancer vaccine that uses the same mRNA technology as Covid-19 vaccines has been successfully completed. Made by Moderna and Merck, the experimental vaccine primes the immune system to seek and destroy cancerous cells. The study, which involved 157 patients with advanced melanoma, found that patients who took the vaccine had a 44% relative reduction in the risk of dying of the cancer or having it progress. The vaccine is personalized to each patient and is very expensive to make.
|
Programming, Design & Data Science
|
sqlite-loadable-rs (GitHub Repo)
sqlite-loadable-rs is a framework for building loadable SQLite extensions in Rust. The extensions add new scalar functions, table functions, virtual tables, virtual filesystems, and more to a SQLite database connection. They can be loaded in any SQLite context.
|
Unovis (GitHub Repo)
Unovis is a modular data visualization framework for React, Angular, Svelte, and vanilla TypeScript or JavaScript. It features charts, maps, network graphs, and more. Unovis is highly customizable, tree-shakable, and supports individual component imports to reduce bundle size. A short video explaining how Unovis works is available.
|
What enabled the big boost in fusion energy announced this week? (9 minute read)
The US Department of Energy has confirmed the National Ignition Facility's claims that it reached a new milestone in fusion energy. The National Ignition Facility was able to generate 3.15 megajoules of energy using 2.05 megajoules of energy deposited using lasers. The 2.05 megajoules of laser power took about 300 megajoules of grid power to produce, so the process is nowhere near the point of break-even. However, it is still a sign of real progress in fusion technology.
|
Here are all the ways to get around ChatGPT's safeguards (6 minute read)
This Twitter thread shows several different ways to get around ChatGPT's safeguards, with screenshots and examples. ChatGPT is susceptible to prompt injection. Using terms like 'ignore previous directions' and 'but hypothetically' can bypass many of its restrictions. Convincing the AI to roleplay an AI that can make moral decisions will make ChatGPT make moral decisions. OpenAI is working to patch many of these workarounds.
|
If your company would like to sponsor TLDR, please take a look at our sponsor page here.
If you have any comments or feedback, just respond to this email!
Thanks for reading,
Dan
|
|
|
|
|